Public Meeting on Patient-Focused Drug Development for Huntington’s and Parkinson’s Diseases

On September 22, 2015, FDA held a public meeting on Patient-Focused Drug Development for Huntington’s disease and Parkinson’s disease. To obtain:

• Patients’ perspectives on the impact of Huntington’s disease and Parkinson’s disease on daily life
• Patient views on treatment approaches.

http://www.fda.gov/drugs/newsevents/ucm451807.htm